Zerwekh Joseph E, Odvina Clarita V, Wuermser Lisa-Ann, Pak Charles Y C
Center for Mineral Metabolism and Clinical Research, and the Department of Physical Medicine and Rehabilitation, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA.
J Urol. 2007 Jun;177(6):2179-84. doi: 10.1016/j.juro.2007.01.156.
Exposure to the microgravity environment of space increases the risk of kidney stone formation, particularly for calcium oxalate and uric acid stones. This study was performed to evaluate the efficacy of potassium alkali as potassium-magnesium citrate in reducing renal stone risk and bone turnover.
This study was performed as a double-blind, placebo controlled trial. We studied 20 normocalciuric subjects randomized to either placebo or potassium-magnesium citrate (42 mEq potassium, 21 mEq magnesium, 63 mEq citrate per day) before and during 5 weeks of strict bed rest. The study was performed in the General Clinical Research Center and under a controlled dietary regimen composed of 100 mEq of sodium, 800 mg of calcium, 0.8 gm/kg animal protein and 2,200 kcal per day. Two 24-hour urine collections were obtained under oil each week for assessment of stone risk parameters and relative saturation of calcium oxalate, brushite and undissociated uric acid. Blood was also collected for determination of serum immunoreactive parathyroid hormone and vitamin D metabolites.
Bed rest promoted a rapid increase in urinary calcium excretion of approximately 50 mg per day in both groups. Despite this increase subjects treated with potassium-magnesium citrate demonstrated significant decreases in the relative saturation of calcium oxalate and in the concentration of undissociated uric acid compared to placebo. Immunoreactive parathyroid hormone, serum 1,25-dihydroxyvitamin D and intestinal calcium absorption all decreased in both groups with no difference in response between the 2 treatment arms.
Provision of alkali as potassium-magnesium citrate is an effective countermeasure for the increased risk of renal stone disease associated with immobilization. Despite an increase in urine calcium concentration, the relative saturation of calcium oxalate decreased due to citrate chelation of calcium and the concentration of undissociated uric acid decreased due to the significant increase in urine pH.
暴露于太空微重力环境会增加肾结石形成的风险,尤其是草酸钙和尿酸结石。本研究旨在评估碱化钾(如枸橼酸钾镁)在降低肾结石风险和骨转换方面的疗效。
本研究为双盲、安慰剂对照试验。我们研究了20名正常钙尿症受试者,在严格卧床休息的5周期间及之前,将他们随机分为安慰剂组或枸橼酸钾镁组(每天42毫当量钾、21毫当量镁、63毫当量枸橼酸盐)。该研究在综合临床研究中心进行,采用由每天100毫当量钠、800毫克钙、0.8克/千克动物蛋白和2200千卡组成的受控饮食方案。每周在油下收集两次24小时尿液,以评估结石风险参数以及草酸钙、透钙磷石和未离解尿酸的相对饱和度。还采集血液以测定血清免疫反应性甲状旁腺激素和维生素D代谢产物。
卧床休息促使两组受试者的尿钙排泄量迅速增加,每天约增加50毫克。尽管有此增加,但与安慰剂相比,接受枸橼酸钾镁治疗的受试者草酸钙的相对饱和度和未离解尿酸的浓度显著降低。两组的免疫反应性甲状旁腺激素、血清1,25 - 二羟维生素D和肠道钙吸收均下降,两个治疗组之间的反应无差异。
提供碱化剂枸橼酸钾镁是应对与固定不动相关的肾结石疾病风险增加的有效对策。尽管尿钙浓度增加,但由于枸橼酸盐对钙的螯合作用,草酸钙的相对饱和度降低,并且由于尿液pH值显著升高,未离解尿酸的浓度降低。